• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,918.76 394.50
( 0.54%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
65,160.26 1,135.66
(1.77%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

Hikal Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524735
INE475B01022
97.2386745
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HIKAL
60.9
2215.1
EPS(TTM)
Face Value()
Div & Yield %
2.95
2
0.22
 

BLS International surges after Q4 PAT rises nearly 29% YoY
May 20,2026

While EBITDA improved by 17.1% YoY to Rs 203.9 crore, EBITDA margin declined by 10 basis points YoY to 25.0% in Q4 FY26.

Accordingly, profit before tax in Q4 FY26 stood at Rs 203.6 crore in Q4 FY26, up by 22.1% from Rs 166.7 crore in Q4 FY25.

For FY26, the company has recorded consolidated net profit and revenue from operations of Rs 723.8 crore (up 34.1% YoY) and Rs 2,998.2 crore (up 36.7% YoY), respectively.

BLS International Services is a global tech-enabled services partner for governments and citizens. It operates in the domain of visa, passport, consular, citizen, e-governance, attestation, biometric, e-visa, and retail services since 2005. The company works with over 46 client governments, including diplomatic missions, embassies, & consulates, and leverages technology and processes that ensure data security.